Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
July 31, 2025

On the Molecular Mechanism of Beta-Amyloid Aggregation Inhibition by KLVFF

View Full Paper
Ask AI
Bookmark
Share

Authors

KCKevin Cobos-MontesSFSebastian FuentesFEFrancisca Estuardo

Discussion

Loading...

Member takes

Overview

Study examines KLVFF's effects on beta-amyloid aggregation in oligomers, suggesting a novel inhibitory mechanism.

Key Points

  • KLVFF peptide inhibits beta-amyloid aggregation, important in Alzheimer's disease and other neurodegenerative disorders.
  • Molecular dynamics revealed KLVFF preferentially binds to the hexamer's lateral face, causing conformational changes.
  • Binding free energy calculations highlight how KLVFF destabilizes the Aβ11-42 hexamer and disrupts structural integrity.
  • CD experiments showed KLVFF reduces beta-strand formation, indicating its concentration-dependent effect on inhibition.

Cite This Study

Cobos-Montes et al. (2025) studied this question.

synapsesocial.com/papers/689a0c5fe6551bb0af8cf5d3https://doi.org/10.26434/chemrxiv-2025-lshn6
View Full Paper
Ask AI
Bookmark
Share